One Health Platform

One Health Platform
Name	One Health Platform
Type	Non-profit network
Founded	2014
Headquarters	Brussels
Region served	Global
Focus	Zoonotic disease, pandemic preparedness, interdisciplinary research

One Health Platform The One Health Platform is an international scientific network coordinating interdisciplinary responses to zoonotic threats, pandemic preparedness, and antimicrobial resistance. It convenes researchers, public health agencies, veterinary institutions, and international organizations to integrate human, animal, and environmental health approaches. The Platform engages with stakeholders across academia, industry, and policy to translate research into practice during outbreaks and health emergencies.

Overview

The One Health Platform unites experts from institutions such as World Health Organization, Food and Agriculture Organization, World Organisation for Animal Health, European Centre for Disease Prevention and Control, and national public health institutes to foster collaborative research and evidence synthesis. Its activities intersect with initiatives like Global Health Security Agenda, Pandemic Influenza Preparedness Framework, International Health Regulations (2005), Coalition for Epidemic Preparedness Innovations, and REACTing. The Platform promotes networks among universities including University of Oxford, Harvard University, Johns Hopkins University, Université de Montréal, and Wageningen University & Research to advance translational science for zoonoses, antimicrobial resistance, and emerging pathogens. Collaboration extends to funding bodies such as European Commission, Horizon 2020, Wellcome Trust, Bill & Melinda Gates Foundation, and National Institutes of Health.

History and Development

The Platform emerged following high-profile outbreaks such as the Ebola virus epidemic in West Africa, Zika virus epidemic, and concerns raised during the 2009 flu pandemic, prompting scientific consortia and advisory groups from institutions like Institut Pasteur, Robert Koch Institute, National Institute for Public Health and the Environment (Netherlands), and Karolinska Institutet to formalize coordination. Early meetings included representatives from European Molecular Biology Laboratory, Academy of Medical Sciences (UK), European Society of Clinical Microbiology and Infectious Diseases, and the G20 Health Ministers discussions that shaped cross-sectoral research agendas. The Platform's workshops and conferences have convened in cities such as Brussels, Geneva, Paris, Stockholm, and Rome, aligning with multilateral processes like United Nations health dialogues and regional strategies by African Union and Association of Southeast Asian Nations.

Organizational Structure and Governance

Governance models draw on practices from entities such as Wellcome Trust, European Research Council, Gavi, the Vaccine Alliance, and United Nations Environment Programme to balance scientific advisory boards, secretariat operations, and stakeholder working groups. The Platform's steering committees often include leaders affiliated with London School of Hygiene & Tropical Medicine, Centers for Disease Control and Prevention, Imperial College London, Pasteur Institute of Dakar, and regional public health agencies like Africa CDC. Funding and accountability mechanisms mirror grant portfolios of European Commission Horizon, National Institutes of Health grants, and philanthropic partnerships seen with Chan Zuckerberg Initiative and Rockefeller Foundation. Operationally, it convenes thematic Task Forces on zoonoses, vaccine research, and diagnostics modeled after consortia such as CEPI and multicenter trials like those coordinated by RECOVERY Trial teams.

One Health Research and Initiatives

Research priorities span surveillance, pathogen discovery, vaccine development, and modeling, linking programmes from Global Virome Project, PREDICT (USAID), FluNet, GISAID, and ProMED-mail for data-sharing and early warning. Collaborative studies involve laboratories such as London School of Hygiene & Tropical Medicine, National Institutes of Health, Institut Pasteur, CSIR-Indian Institute of Chemical Technology, and Chinese Center for Disease Control and Prevention to investigate spillover dynamics, host–pathogen interactions, and antimicrobial stewardship alongside partners like OIE and FAO. Initiatives include multidisciplinary consortia on bat-borne viruses similar to projects at Smithsonian Institution, ecological surveillance projects inspired by EcoHealth Alliance, and vaccine platform research reflecting work at Moderna, AstraZeneca, and Pfizer. Modeling collaborations draw expertise from Imperial College London, London School of Hygiene & Tropical Medicine, Met Office Hadley Centre, and Santa Fe Institute to inform non-pharmaceutical interventions and resource allocation.

Policy, Education, and Capacity Building

The Platform supports policy dialogues engaging ministries exemplified by Ministry of Health (France), Ministry of Health and Family Welfare (India), Ministry of Health and Social Affairs (Sweden), and intergovernmental consultations with European Commission Directorate-General for Health and Food Safety and World Bank. Educational efforts partner with universities such as University of Cambridge, McGill University, Tufts University, University of Pretoria, and training programmes akin to those by CDC Field Epidemiology Training Program and WHO Collaborating Centres. Capacity building includes laboratory strengthening informed by standards from International Organization for Standardization, biosafety guidance from World Health Organization, and workforce development modeled on Global Outbreak Alert and Response Network and Public Health England training curricula.

Challenges and Criticisms

Critics reference tensions seen in debates involving EcoHealth Alliance, controversies around gain-of-function research highlighted by discussions at United States National Academies of Sciences, Engineering, and Medicine, and geopolitical frictions among actors like United States, China, and European Union that complicate data-sharing. Challenges include sustainable financing resembling issues faced by Gavi and Global Fund to Fight AIDS, Tuberculosis and Malaria, coordination across sectors comparable to hurdles in Sustainable Development Goals implementation, and reconciling diverse stakeholder priorities reminiscent of debates in Convention on Biological Diversity. Ethical and legal concerns echo deliberations at bodies such as Council of Europe and United Nations Educational, Scientific and Cultural Organization regarding biosafety, benefit-sharing, and intellectual property.

Category:Public health organizations Category:Global health